Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acetylcholine
16%
Active Pharmaceutical Ingredients
16%
Antidepressant Compounds
16%
Antioxidant Effect
16%
Beta-blockers
16%
Cell Viability
16%
Cell-based
100%
Cellular Bioenergetics
16%
Diabetes
16%
Diabetic Cardiovascular Complications
16%
Diabetic Endothelial Dysfunction
100%
Drug-likeness
16%
Endothelial Cell Injury
16%
Endothelial Cells
33%
Endothelium-dependent
16%
Experimental Therapeutics
16%
Focused Library
16%
Hit Rate
16%
Hyperglycemia
66%
In Vitro Model
16%
Mitochondrial DNA Damage
16%
Mitochondrial Electron Transport
16%
Mitochondrial Proteins
16%
Mitochondrial Reactive Oxygen Species (mtROS)
16%
Nuclear DNA Damage
16%
Paroxetine
100%
Pharmacological Activities
16%
Pharmacologically Active Compounds
16%
Phenotypic Screening
16%
Protector
16%
Protein Oxidation
16%
Rat Model
16%
Reactive Oxygen Species Generation
33%
Relaxor
16%
Repurposing
16%
Serotonin Reuptake
16%
Sesamol
16%
Streptozotocin-induced Diabetes
16%
Vascular Ring
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylcholine
16%
Antidepressant
16%
Antioxidant
16%
Cardiovascular Disease
16%
Cell Nucleus DNA
16%
Cell Viability
16%
Drug Action
16%
Endothelial Dysfunction
100%
Glucose
16%
Hyperglycemia
66%
Mitochondrial DNA
16%
Mitochondrial Protein
16%
Paroxetine
100%
Rat Model
16%
Reactive Oxygen Metabolite
33%
Repurposing
16%
Reuptake Blocker
16%
Serotonin
16%
Streptozotocin-Induced Diabetes Mellitus
16%
Vascular Ring
16%